Activated PI3Kδ breaches multiple B cell tolerance checkpoints and causes autoantibody production

Journal: Journal of Experimental Medicine

Published: 2020-02-03

DOI: 10.1084/jem.20191336

Affiliations: 21

Authors: 25

Go to article
Institutions Share
Immunity and Inflammatory Diseases, Garvan Institute of Medical Research, Australia 0.31
Clinical Immunogenomics Research Consortium Australia (CIRCA), Australia 0.15
Department of Allergy and Immunology, RCH, Australia 0.12
St Vincent's Clinical School (STVCS), UNSW Sydney, Australia 0.09
NIH NIAID Laboratory of Clinical Immunology and Microbiology (LCIM), United States of America (USA) 0.08
Children's Hospital at Westmead (CHW), USYD, Australia 0.04
Department of Microbiology, Immunology and Transplantation, KU Leuven, Belgium 0.02
Department of Paediatrics, UZ Leuven, Belgium 0.02
Princess Margaret Hospital for Children (PMH), Australia 0.02
Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, and Maternal and Children's Sciences (DINOGMI), University of Genova, Italy 0.02
School of Women's and Children's Health (SPHCM), UNSW Sydney, Australia 0.02
IRCCS Istituto Giannina Gaslini, Italy 0.02
Faculty of Medicine and Health, USYD, Australia 0.01
Westmead Hospital (WSLHD), Australia 0.01
Cellular Genomics Futures Institute, UNSW Sydney, Australia 0.01
Faculty of Medicine, UNSW Sydney, Australia 0.01
Vienna Center for Rare and Undiagnosed Diseases (CeRUD) / Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases (LBI-RUD), Austria 0.01
Research Center for Molecular Medicine (CeMM), ÖAW, Austria 0.01
St. Anna Children’s Hospital, Austria 0.01
Department of Pediatrics and Adolescent Medicine, MUW, Austria 0.01
St. Anna Children's Cancer Research Institute (CCRI), Austria 0.01